European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT02495974 · clinicaltrials.gov ↗

COMPLETED

Status

1763

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer

Interventions

DRUG: enzalutamide

Sponsor

Astellas Pharma Europe Ltd.

Collaborators

[object Object]